| J&J schizophrenia drug gets conditional approval (Reuters) - in yahoo news - Reuters - Johnson & Johnson on Friday said U.S. health regulators would not approve the company's next-generation schizophrenia drug, paliperidone extended-release, until certain conditions are met. |